Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$0.42 - $0.72 $2,131 - $3,654
-5,075 Reduced 93.65%
344 $0
Q2 2023

Jul 17, 2023

BUY
$1.05 - $1.63 $361 - $560
344 Added 6.78%
5,419 $6,000
Q1 2023

Apr 17, 2023

BUY
$1.2 - $2.73 $6,090 - $13,854
5,075 New
5,075 $6,000
Q1 2021

Apr 15, 2021

BUY
$33.06 - $56.93 $7,438 - $12,809
225 New
225 $8,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.